Why is Transgene Biotek falling/rising?

As of 04-Nov, Transgene Biotek Ltd is experiencing a decline in its stock price, currently at 3.68, which represents a decrease of 0.12 or 3.16%. The stock has underperformed its sector today by 2.81% and has shown a trend reversal, falling after two consecutive days of gains. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The stock has also seen a significant drop in investor participation, with delivery volume falling by 55.3% against the 5-day average. Over the past week, the stock has declined by 11.96%, while it has fallen 12.17% over the past month, and it has a year-to-date decline of 46.12%.
In the broader market context, the Sensex has only declined by 1.38% over the past week, indicating that Transgene Biotek's performance is significantly worse than the overall market. While the benchmark has shown a positive return of 2.77% over the past month, Transgene Biotek's negative returns highlight its struggles relative to the market. The stock's long-term performance is also concerning, with a 46.28% decline over the past year compared to a 5.94% increase in the Sensex. This stark contrast suggests that investor sentiment towards Transgene Biotek is weak, contributing to its recent price drop.